Use of acetylated tubulin as a biomarker of drug response to furazanobenzimidazoles
- 专利权人:
- 发明人:
- Heidi Alexandra Lane,Felix Bachmann
- 申请号：
- US15294157
- 公开号：
- US10067120B2
- 申请日:
- 2016.10.14
- 申请国别(地区):
- US
- 年份:
- 2018
- 代理人:
- 摘要：
- Use of acetylated tubulin as a biomarker for predicting the response to a compound, preferably resistance of a disease such as cancer in a subject to said compound, wherein the compound is a furazanobenzimidazoles compound of general formula (I).
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- IMMUNE RESPONSE CONTROLLING AGENT
- Application of lipopolysaccharide (LPS) in treatment of states or diseases connected with excessive organism immunity response, caused by chronic illnesses of digestive system, preferably from the group of unspecific inflammatory bowel disease (IBD) and/or food allergies
- Biomarkers for multitargeted immunotherapy
- PURE NON-INVASIVE METHOD FOR IDENTIFICATION OF ORGAN DISEASES OR IMPAIRED ORGAN FUNCTION BY INVESTIGATION OF MARKER SUBSTANCES IN EXHALED AIR STIMULATED BY INHALED MARKER SUBSTANCES
- PURE NON-INVASIVE METHOD FOR IDENTIFICATION OF ORGAN DISEASES OR IMPAIRED ORGAN FUNCTION BY INVESTIGATION OF MARKER SUBSTANCES IN EXHALED AIR STIMULATED BY INHALED MARKER SUBSTANCES
